Mfg Part Number
Ab00296-25.0

Vector Labs Ab00296-25.0 Anti-C5 [Eculizumab], Human IgG2/4, kappa (200 μg)

Quick Overview
C5 is activated by C5 converatse into C5a, an anaphylatoxin, and C5b a component of the membrane attack complex.
$517.40
Order will ship within 1-3 business days
Add to Wish List
Product Class:Purified
Expected Species Reactivity:Human
Clone ID:Eculizumab
Synonyms:Complement Component 5; CPAMD4; Complement protein C5; h5G1.1
Amount:200 μg
Application Codes Clone:Block; EM; ELISA
Shipping Temperature:Wet Ice
Buffer Composition:PBS with 0.02% Proclin 300.
Original Format:IgG2/4
Storage Temperature:Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at -20⁰C.
Chimeric Use Statement:NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.
Specificity Statement:Binds human C5 centred in the MG7 domain, at an epitope spanning Lys-879 to Arg-885 (Jore et al. 2016) Polymorphisms at Arg-885 correlate with drug resistance. Eculizumab demonstrates no appreciable species cross-reactivity. It is highly species specific. with no appreciable activity against chimpanzee, baboon, rhesus or cynomologous monkey, pig, rabbit, guinea pig, or rat complement
Application Notes:This antibody inhibits activation of C5. The human Fab version (Ab00296-10.6) of this antibody was used by Jore et al. (2016, PMID: 27018802) to determine the binding site of this antibody to C5.
More Information
Brand Vector Labs
UNSPSC 12161500